Market Dynamics of Glucagon Like Peptide-1 Agonists: A 2031 Perspective The growing burden of type 2 diabetes across developed and developing economies has significantly increased the demand for advanced therapeutic solutions. Healthcare providers are increasingly adopting innovative injectable therapies that improve glycemic control while supporting long term disease management. Rising awareness regarding obesity management and metabolic disorders is also...
0 condivisioni
78 Views
0 Anteprima